Rapid RV/LV vs ClearRead CT
AI Verdict
Choose Rapid RV/LV if…
Choose Rapid RV/LV if your primary need is a rapid, automated assessment of pulmonary embolism (PE) severity from CTPA scans. This tool is ideal for emergency departments or critical care settings where quick, objective measurements of RV/LV ratios are crucial for immediate patient triage and guiding treatment decisions for suspected PE cases.
View Rapid RV/LV →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on enhancing the detection and characterization of pulmonary nodules and performing coronary artery calcification (CAC) scoring. This tool is best suited for lung cancer screening programs, long-term nodule surveillance, and cardiovascular risk assessment, where improved diagnostic accuracy and streamlined workflow for comprehensive cardiothoracic CT analysis are paramount.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid RV/LV | ClearRead CT |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Contact for pricing |
| Deployment | Unknown | On-premise (stand-alone server, virtual machine) and Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid RV/LVRapid RV/LV, as part of the broader RapidAI platform, offers a more comprehensive usability experience. It provides rapid results, annotated images, and a dedicated web app and mobile app for real-time notifications, communication, and care coordination across various team members and devices, extending its utility beyond the reading workstation.
Clinical Value
ClearRead CTClearRead CT demonstrates a broader clinical impact by enhancing both pulmonary nodule detection (including all nodule types) and coronary artery calcification analysis. Clinical trials show a significant 29% reduction in missed actionable nodules and reduced reading times, addressing a wider range of cardiothoracic health issues with strong, quantified improvements in diagnostic accuracy.
Pricing & Value
Rapid RV/LVWhile both tools require direct vendor contact for pricing, RapidAI provides some insight into its custom enterprise pricing model, which is based on factors like institution size and modules needed. External recognition from Frost & Sullivan also highlights RapidAI's ability to deliver value and cost-benefit advantages to hospitals, suggesting a more articulated value proposition.
Enterprise Readiness
Rapid RV/LVRapid RV/LV, as part of the RapidAI platform, explicitly states HIPAA and BAA compliance and boasts a comprehensive array of security certifications including GDPR, ISO 13485, ISO 27001, ISO 27701, and SOC2 Type 1. This extensive list of documented certifications and a robust cybersecurity framework provides a higher level of explicitly stated enterprise readiness.
Innovation
Rapid RV/LVRapidAI demonstrates broader and more recent innovation with its 'Deep Clinical AI' approach that goes beyond triage to characterize, quantify, and track changes. Its Lumina 3D technology was recognized as one of TIME's Best Inventions of 2025 for automated 3D reconstructions, showcasing a wider range of advanced AI applications and industry recognition.
Support & Docs
Rapid RV/LVRapidAI offers 24/7/365 global customer support via email and phone, along with comprehensive resources, education, and an efficient implementation process that typically goes live within two weeks. This round-the-clock availability provides a superior level of continuous support compared to Tool B's extended business hours.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid RV/LV | ClearRead CT |
|---|---|---|
| Primary Clinical Focus | Rapid assessment of pulmonary embolism severity. | Enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| Specific AI Analysis/Measurements | Automated measurement of right and left ventricle diameters, calculation of RV/LV ratio from CTPA scans. | Pulmonary Nodule Detection (solid, part-solid, ground glass), Nodule Characterization and Measurement (volume, diameter, location, type, depth), Automated Nodule Tracking and Comparison to Prior Exams, Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs). |
| Key Differentiating Technology | AI-powered analysis of CTPA images, annotated images showing ventricular measurements, rapid results (within minutes). | Patented Vessel Suppression (Clear Visual Intelligence), AI-Driven Clarity. |
| Target Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Pulmonology, Radiology |
| Integration Capabilities | Integration with Rapid PE solution, Triage and notification capabilities (as part of the broader Rapid platform). | Seamless PACS Integration / Vendor-neutral processing. |
Videos
Demos, reviews, and walkthroughs featuring Rapid RV/LV and ClearRead CT.